Blood gene expression signatures associate with heart failure outcomes

Physiological Genomics

Volumn 43, Issue 8, 2011, Pages 392-397

  vanBuren, Peter ^a   Ma, Jun ^b   Chao, Samuel ^b   Mueller, Enkhtuyaa ^a   Schneider, David J ^a   Liew, Choong Chin ^b,c  

^a UNIVERSITY OF VERMONT   (United States)

^b GeneNews Limited   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Gene expression profiling; Microarray; Survival analysis

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CLUSTER ANALYSIS; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; HEART FAILURE; HUMANS; MICROARRAY ANALYSIS; MIDDLE AGED; PROGNOSIS; RECEPTORS, ANTIGEN, T-CELL; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79955757263     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00175.2010     Document Type: Article

References (20)

1. Aronow BJ, Toyokawa T, Canning A, Haghighi K, Delling U, Kranias E, Molkentin JD, Dorn GW. Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy. Physiol Genomics 6: 19-28, 2001.
2. Aukrust P, Ueland T, Lien E, Bendtzen K, Muller F, Andreassen AK, Nordoy I, Aass H, Espevik T, Simonsen S, Froland SS, Gullestad L. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 83: 376-382, 1999.
3. Braunwald E. Biomarkers in heart failure. N Engl J Med 358: 2148-2159, 2008.
4. Braunwald E, Bristow MR. Congestive heart failure: fifty years of progress. Circulation 102: IV14-IV23, 2000.
5. Cunha-Neto E, Dzau VJ, Allen PD, Stamatiou D, Benvenutti L, Higuchi ML, Koyama NS, Silva JS, Kalil J, Liew CC. Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. Am J Pathol 167: 305-313, 2005.
6. Kapadia S, Dibbs Z, Kurrelmeyer K, Kalra D, Seta Y, Wang F, Bozkurt B, Oral H, Sivasubramanian N, Mann DL. The role of cytokines in the failing human heart. Cardiol Clin 16: 645-56, 1998.
7. Kittleson MM, Minhas KM, Irizarry RA, Ye SQ, Edness G, Breton E, Conte JV, Tomaselli G, Garcia JG, Hare JM. Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. Physiol Genomics 21: 299-307, 2005.
8. Ma J, Dempsey AA, Stamatiou D, Marshall KW, Liew CC. Identifying leukocyte gene expression patterns associated with plasma lipid levels in human subjects. Atherosclerosis 191: 63-72, 2007.
9. Ma J, Liew CC. Gene profiling identifies secreted protein transcripts from peripheral blood cells in coronary artery disease. J Mol Cell Cardiol 35: 993-998, 2003.
10. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347: 161-167, 2002.
11. Mann DL. Targeted anticytokine therapy and the failing heart. Am J Cardiol 95: 9C-16C, 2005.
12. Mann DL, Bristow MR. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 111: 2837-2849, 2005.
13. Margulies KB, Bednarik DP, Dries DL. Genomics, transcriptional profiling, and heart failure. J Am Coll Cardiol 53: 1752-1759, 2009.
14. Ommen SR, Hodge DO, Rodeheffer RJ, McGregor CG, Thomson SP, Gibbons RJ. Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation 97: 19-22, 1998.
15. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S. Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation 98: 149-156, 1998.
16. Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, Vuillomenet A, Jeker U, Dubach P, Beer H, Yoon SI, Suter T, Osterhues HH, Schieber MM, Hilti P, Schindler R, Brunner-LaRocca HP. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. JAMA 301: 383-392, 2009.
17. Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP, Jacobsen SJ. Trends in heart failure incidence and survival in a community-based population. JAMA 292: 344-350, 2004.
18. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100: 9440-9445, 2003.
19. Toth MJ, Ades PA, Tischler MD, Tracy RP, LeWinter MM. Immune activation is associated with reduced skeletal muscle mass and physical function in chronic heart failure. Int J Cardiol 109: 179-187, 2006.
20. Wu Z, Irizarry RA, Gentleman R, Murillo RM, Spencer F. A model based background adjustment for oligonucleotide expression arrays. Johns Hopkins University, Dept. of Biostatistics Working Papers: Working Paper 1, 2004.